Q4 2023 Holdings
Filed 2024-02-14 | 30 holdings | $140.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $17.7M | 598,072 | 12.7% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $14.8M | 177,603 | 10.6% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $11.4M | 1,021,477 | 8.1% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $9.6M | 189,618 | 6.8% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $8.9M | 251,295 | 6.4% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $8.7M | 379,143 | 6.2% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $8.6M | 203,592 | 6.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $8.3M | 206,326 | 5.9% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $5.5M | 379,626 | 4.0% |
| Marinus Pharmaceuticals Inc(MRNS*) | COM NEW | 56854Q200 | $5.0M | 462,444 | 3.6% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $3.9M | 29,346 | 2.8% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $3.8M | 255,430 | 2.7% |
| Savara Inc(SVRA) | COM | 805111101 | $3.8M | 814,266 | 2.7% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $3.7M | 326,161 | 2.6% |
| Lantheus Hldgs Inc(LNTH) | COM | 516544103 | $3.4M | 54,896 | 2.4% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $3.2M | 847,823 | 2.3% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $3.0M | 74,649 | 2.1% |
| Acelyrin Inc | COM | 00445A100 | $2.7M | 356,924 | 1.9% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $2.5M | 124,040 | 1.8% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $2.3M | 347,381 | 1.6% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $2.0M | 16,086 | 1.4% |
| Quanterix Corp(QTRX) | COM | 74766Q101 | $2.0M | 71,760 | 1.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $1.3M | 16,179 | 0.9% |
| SO Young International Inc(SY) | SPONSORED ADS | 83356Q108 | $1.0M | 796,059 | 0.7% |
| Immatics N.v(IMTX) | SHS | N44445109 | $834.1K | 79,213 | 0.6% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $713.0K | 222,112 | 0.5% |
| Inozyme Pharma Inc | COM | 45790W108 | $528.0K | 123,944 | 0.4% |
| Fusion Pharmaceuticals Inc | COM | 36118A100 | $440.1K | 45,801 | 0.3% |
| Spruce Biosciences Inc | COM | 85209E109 | $348.1K | 118,814 | 0.2% |
| YS Biopharma Co LTD | ORDINARY SHARES | G9845F109 | $165.7K | 307,920 | 0.1% |